Articles
-
-
Circadian clocks, cognition, and Alzheimer’s disease: synaptic mechanisms, signaling effectors, and chronotherapeutics
-
Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
-
BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia
-
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
-
The neuropathological diagnosis of Alzheimer’s disease
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
-
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
-
α-Synuclein and neuronal cell death
Editor highlights
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
News from Alzforum
Contact the Managing Editorial Team
Hongmei Li - Hongmei.Li@MolecularNeurodegeneration.org
Lucy Job - Lucy.Job@MolecularNeurodegeneration.org
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Follow
Annual Journal Metrics
-
Speed
20 days to first decision for all manuscripts
58 days to first decision for reviewed manuscripts only
153 days from submission to acceptance
28 days from acceptance to publication
Citation Impact
14.195 - 2-year Impact Factor
11.684 - 5-year Impact Factor
2.172 - Source Normalized Impact per Paper (SNIP)
5.565 - SCImago Journal Rank (SJR)
Usage
1,034,660 downloads (2021)
723 Altmetric mentions